SYMPATHOEXCITATION References

1.            Alvarez GG, and Ayas NT. The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs 19: 56-59, 2004.

2.            Burgess KR. Central sleep apnoea and heart failure (part II). Respirology 3: 1-11, 1998.

3.            Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 33: 475-482, 2007.

4.            Chasens ER, Weaver TE, and Umlauf MG. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link? Biol Res Nurs 5: 87-96, 2003.

5.            Chiariello M, and Perrone-Filardi P. Pathophysiology of heart failure. Miner Electrolyte Metab 25: 6-10, 1999.

6.         de Groen JH, Op den Velde W, Hovens JE, Falger PR, Schouten EG, and van Duijn H. Snoring and anxiety dreams. Sleep 16: 35-36, 1993.

7.            Figueroa MS, and Peters JI. Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care 51: 403-412, 2006.

8.            Gabrielsen A, Sorensen VB, Pump B, Galatius S, Videbaek R, Bie P, Warberg J, Christensen NJ, Wroblewski H, Kastrup J, and Norsk P. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 279: H1931-1940, 2000.

9.            Gehlbach BK, and Geppert E. The pulmonary manifestations of left heart failure. Chest 125: 669-682, 2004.

10.            Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, and Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49: 535-541, 2007.

11.       Gur S, Kadowitz PJ, and Hellstrom WJ. Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction. Drugs 68: 209-229, 2008.

12.            Guyenet PG. Neural structures that mediate sympathoexcitation during hypoxia. Respir Physiol 121: 147-162, 2000.

13.            Harsch IA, Schahin SP, Bruckner K, Radespiel-Troger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T, and Ficker JH. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71: 252-259, 2004.

14.            Klingelhofer J, and Sander D. Cardiovascular consequences of clinical stroke. Baillieres Clin Neurol 6: 309-335, 1997.

15.            Kocsis B, and Gyimesi-Pelczer K. Activation of the 10-Hz sympathetic generator during the second phase of severe hypoxia-hypercapnia and Cushing reaction. Auton Neurosci 98: 41-44, 2002.

16.            Makaritsis KP, Liakopoulos V, Leivaditis K, Eleftheriadis T, and Stefanidis I. Adaptation of renal function in heart failure. Ren Fail 28: 527-535, 2006.

17.            Manthey J, Dietz R, Opherk D, Osterziel KJ, Leinberger H, and Kubler W. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol 70: 224-228, 1992.

18.            McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism 55: S20-23, 2006.

19.            McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 Suppl 2: 23-28; discussion 44-25, 2006.

20.            Mellman TA, and Hipolito MM. Sleep disturbances in the aftermath of trauma and posttraumatic stress disorder. CNS Spectr 11: 611-615, 2006.

21.            Narkiewicz K, and Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177: 385-390, 2003.

22.            Olmetti F, La Rovere MT, Robbi E, Taurino AE, and Fanfulla F. Nocturnal cardiac arrhythmia in patients with obstructive sleep apnea. Sleep Med 2007.

23.       Pillar G, and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31 Suppl 2: S303-309, 2008.

24.            Punjabi NM, and Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99: 1998-2007, 2005.

25.       Rao J, Yang J, Liu Z, Wang L, Yin Z, Liu L, He Q, and Yang L. Hypothetic association between greater sympathetic activity and prostate cancer. Med Hypotheses 2008.

26.            Rosen RC. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol 16: 11-19, 2006.

27.            Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119: S47-53, 2006.

28.            Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, and Ohi M. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 57: 429-434, 2002.

29.       Sica DA. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 Suppl 2: S2-7; discussion S30-33, 2006.

30.       Strohl KP, Boehm KD, Denko CW, Novak RD, and Decker MJ. Biochemical morbidity in sleep apnea. Ear Nose Throat J 72: 34, 39-41, 1993.

31.       Sulit L, Storfer-Isser A, Kirchner HL, and Redline S. Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 29: 777-783, 2006.

32.            Ullrich PM, Lutgendorf SK, and Kreder KJ. Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia. Urology 70: 487-491; discussion 491-482, 2007.

33.       Yun AJ, Lee PY, and Bazar KA. Autonomic dysregulation as a basis of cardiovascular, endocrine, and inflammatory disturbances associated with obstructive sleep apnea and other conditions of chronic hypoxia, hypercapnia, and acidosis. Med Hypotheses 62: 852-856, 2004.